Brain cell transplant trial offers hope for Huntington's patients
Disease control
Recruiting now
This early-stage trial tests whether implanting human neural stem cells into the brain is safe for people with Huntington's disease. About 21 adults aged 18-65 with a confirmed genetic diagnosis will receive the cells and be monitored for side effects. The goal is to see if the p…
Phase: PHASE1, PHASE2 • Sponsor: Leslie Thompson • Aim: Disease control
Last updated May 18, 2026 12:10 UTC